PII Acquires Pharmaterials Ltd
BALTIMORE, Md., January 3, 2008 – PII (Pharmaceutics International, Inc.) has acquired Pharmaterials Ltd (Reading, UK), an internationally renowned preformulation and formulation development company. This acquisition will extend the business development initiatives and increase the value of the service offerings of PII.
Steve King, Senior VP of PII stated “PII offers a very wide
range of cGMP production and formulation development services which
have been expanded through alliances in drug delivery
ventures. This acquisition of Pharmaterials will enable PII
to provide a complete service for our customer base.
”
Professor Graham Buckton, Chief Executive and founder of
Pharmaterials, said “PII is a company that provides an
excellent service to their wide client base. They have a
state of the art facility with a staff of over 300 providing
formulation and manufacturing services. The success that they
have seen is based on providing value to their customers, which is
the same philosophy at Pharmaterials. Working together we
will be able to provide preformulation, polymorphism, salt
screening and co-crystal services to PII’s existing
customers. In addition, they can provide new options in cGMP
transfer to enhance services at Pharmaterials.”
PII (www.pharm-int.com) is a contract
formulation development, Clinical Trail Materials (CTM) and
commercial manufacturing company based in Hunt Valley,
Maryland. Founded in 1994, PII can manufacture most solid and
semi-solid dosage forms for use in clinical trials and commercial
sale. These services are complemented by full analytical and
regulatory support. The state of the art cGMP facility
contains on-site manufacturing suites, analytical laboratories and
warehouse space. The company has a balanced client base of
major multinational and virtual pharmaceutical companies that are
primarily focused in the United States and Europe.
Pharmaterials Ltd (www.pharmaterials.co.uk) is a technology driven contract research organization specializing in the optimization of drug substance physical forms and formulations to facilitate the development of low solubility and poorly permeable drug substances. With partnerships that span the globe, Pharmaterials works with a range of organizations including start-up, mid-size and multinational companies. Founded in January 2000 by Professor Graham Buckton, the company has exponentially expanded through implementation of an organic business model. Pharmaterials is housed in state-of-the-art laboratories and offices in Reading, UK and has offices in Tokyo to support their increasing Japanese client base.
####
Contact:
Steve King, Sr. Vice President
Pharmaceutics International, Inc.
10819 Gilroy Road
Hunt Valley, MD 21031
Phone: 410 584-0001
Email: sjking@pharm-int.com
Pharma Industry News Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec
